Cite
HARVARD Citation
Macdonald, D. et al. (n.d.). A phase I/II study of sorafenib in combination with low dose cytarabine in elderly patients with acute myeloid leukemia or high-risk myelodysplastic syndrome from the National Cancer Institute of Canada Clinical Trials Group: trial IND.186. Leukemia & lymphoma. 54 (4), pp. 760-766. [Online].